{"id":4240,"date":"2024-05-07T16:00:17","date_gmt":"2024-05-07T20:00:17","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/assemblee-generale-mixte-du-29-mai-2024\/"},"modified":"2026-09-24T00:05:51","modified_gmt":"2026-09-24T04:05:51","slug":"assemblee-generale-mixte-du-29-mai-2024","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/","title":{"rendered":"Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Paris, France, le 7 mai 2024, 18:00 CEST<\/strong> \u2013 GenSight Biologics (Euronext\u00a0: SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour le traitement des maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce la tenue de son Assembl\u00e9e G\u00e9n\u00e9rale Mixte le 29 mai 2024 \u00e0 9h00 au si\u00e8ge social de la Soci\u00e9t\u00e9, 74 rue du Faubourg Saint-Antoine, 75012 Paris, France.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019Assembl\u00e9e G\u00e9n\u00e9rale sera \u00e9galement retransmise en direct pour les actionnaires sur le site Internet de la Soci\u00e9t\u00e9 (<a href=\"https:\/\/www.gensight-biologics.com\">www.gensight-biologics.com<\/a>).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019avis pr\u00e9alable comportant l\u2019ordre du jour et les projets de r\u00e9solutions a \u00e9t\u00e9 publi\u00e9 au <em>BALO<\/em> du 24 avril 2024. L\u2019avis de convocation sera publi\u00e9 au <em>BALO<\/em> et dans un journal d\u2019annonces l\u00e9gales le 13 mai 2024.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les documents pr\u00e9paratoires \u00e0 l\u2019Assembl\u00e9e \u00e9nonc\u00e9s par l\u2019article R. 22-10-23 du Code de commerce sont mis en ligne sur le site Internet de la Soci\u00e9t\u00e9 (<a href=\"https:\/\/www.gensight-biologics.com\">www.gensight-biologics.com<\/a>).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les documents pr\u00e9paratoires \u00e0 l\u2019Assembl\u00e9e seront \u00e9galement tenus \u00e0 la disposition des actionnaires \u00e0 compter de la convocation de l\u2019Assembl\u00e9e.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Il est pr\u00e9cis\u00e9 que le texte int\u00e9gral des documents destin\u00e9s \u00e0 \u00eatre pr\u00e9sent\u00e9s \u00e0 l&rsquo;Assembl\u00e9e, conform\u00e9ment notamment aux articles L. 225-115 et R. 225-83 du Code de commerce, sont mis \u00e0 disposition au si\u00e8ge social.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Jusqu&rsquo;au cinqui\u00e8me jour inclusivement avant la r\u00e9union, tout actionnaire peut demander \u00e0 la Soci\u00e9t\u00e9 de lui adresser les documents et renseignements mentionn\u00e9s aux articles R. 225-81 et R. 225-83 du Code de commerce, de pr\u00e9f\u00e9rence par email \u00e0 l\u2019adresse suivante\u00a0: <a href=\"mailto:ir@gensight-biologics.com\">ir@gensight-biologics.com<\/a>.. Les actionnaires au porteur doivent justifier de cette qualit\u00e9 par la transmission d&rsquo;une attestation d&rsquo;inscription en compte.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong>Modalit\u00e9s de mise \u00e0 disposition des documents pr\u00e9paratoires \u00e0 l\u2019Assembl\u00e9e<\/strong><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[54],"tags":[],"featured-area":[],"news-topic":[85],"news-type":[82],"post-year":[],"class_list":["post-4240","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse-financiers","news-topic-general-meeting","news-type-general-meeting"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024 - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024 - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Modalit\u00e9s de mise \u00e0 disposition des documents pr\u00e9paratoires \u00e0 l\u2019Assembl\u00e9e\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-07T20:00:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-24T04:05:51+00:00\" \/>\n<meta name=\"author\" content=\"jbenedicto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"jbenedicto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/05\\\/07\\\/assemblee-generale-mixte-du-29-mai-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/05\\\/07\\\/assemblee-generale-mixte-du-29-mai-2024\\\/\"},\"author\":{\"name\":\"jbenedicto\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"headline\":\"Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024\",\"datePublished\":\"2024-05-07T20:00:17+00:00\",\"dateModified\":\"2026-09-24T04:05:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/05\\\/07\\\/assemblee-generale-mixte-du-29-mai-2024\\\/\"},\"wordCount\":316,\"articleSection\":[\"Communiqu\u00e9 de presse Financier\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/05\\\/07\\\/assemblee-generale-mixte-du-29-mai-2024\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/05\\\/07\\\/assemblee-generale-mixte-du-29-mai-2024\\\/\",\"name\":\"Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024 - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2024-05-07T20:00:17+00:00\",\"dateModified\":\"2026-09-24T04:05:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/05\\\/07\\\/assemblee-generale-mixte-du-29-mai-2024\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/05\\\/07\\\/assemblee-generale-mixte-du-29-mai-2024\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/05\\\/07\\\/assemblee-generale-mixte-du-29-mai-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\",\"name\":\"jbenedicto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"caption\":\"jbenedicto\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024 - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/","og_locale":"fr_FR","og_type":"article","og_title":"Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024 - GenSight Biologics","og_description":"Modalit\u00e9s de mise \u00e0 disposition des documents pr\u00e9paratoires \u00e0 l\u2019Assembl\u00e9e","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/","og_site_name":"GenSight Biologics","article_published_time":"2024-05-07T20:00:17+00:00","article_modified_time":"2026-09-24T04:05:51+00:00","author":"jbenedicto","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"jbenedicto","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/"},"author":{"name":"jbenedicto","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"headline":"Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024","datePublished":"2024-05-07T20:00:17+00:00","dateModified":"2026-09-24T04:05:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/"},"wordCount":316,"articleSection":["Communiqu\u00e9 de presse Financier"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/","name":"Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024 - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2024-05-07T20:00:17+00:00","dateModified":"2026-09-24T04:05:51+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/05\/07\/assemblee-generale-mixte-du-29-mai-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Assembl\u00e9e G\u00e9n\u00e9rale Mixte du 29 mai 2024"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f","name":"jbenedicto","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","caption":"jbenedicto"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=4240"}],"version-history":[{"count":2,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4240\/revisions"}],"predecessor-version":[{"id":6981,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4240\/revisions\/6981"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=4240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=4240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=4240"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=4240"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=4240"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=4240"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=4240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}